title: [Immune status against measles and rubella among 4 Chilean groups of different ages].
abstract: BACKGROUND
  Results of clinical and epidemiological studies confirm that no cases of measles have occurred in Chile since 1993. However, since covering of vaccination programs do not exceed 95%, an immunological surveillance for this disease is warranted.
  
  
  OBJECTIVE
  To know the immune status against measles and rubella in the Chilean population.
  
  
  METHODS
  A serological census of a representative sample of communities with high (90% or more) or low immunization coverings was performed. Four sub samples along the country were selected: 122 children aged 18 months of age (stratum A), 1,276 children attending the first years of basic school (stratum B), 899 teenagers in their last high school year (stratum C) and 399 women attending a family planning clinic (stratum D). IgG antibodies against measles and rubella were measured using ELISA and hemagglutination inhibition techniques, respectively.
  
  
  RESULTS
  Antibodies against measles and rubella were found in 96% and 94% of study subjects. No differences in these titres were found between different strata or communities with high or low vaccination covering. There is a high percentage of positive antibodies against measles among children of 18 months of age and a high percentage of antibodies against rubella among teenagers and women in family planning. Only 3% of the sample had not received any vaccine at the moment of the study.
  
  
  CONCLUSIONS
  The high prevalence of antibodies against rubella allows to conclude that it is not necessary to consider this antigen in the next vaccination campaign. Due to the high prevalence of antibodies against measles, only the population older than 20 years old should be affected by the disease if this virus enters the country.
authors.affiliation: Organización Panamericana de la Salud, Instituto de Salud Pública, Santiago de Chile, Chile.
authors.forename: M T
authors.initials: MT
authors.lastname: Valenzuela
authors.forename: J
authors.initials: J
authors.lastname: Vega
authors.forename: I
authors.initials: I
authors.lastname: Leal
authors.forename: M
authors.initials: M
authors.lastname: Vicente
authors.forename: V
authors.initials: V
authors.lastname: Young
authors.forename: L
authors.initials: L
authors.lastname: Vera
authors.forename: R
authors.initials: R
authors.lastname: Fasce
authors.forename: E
authors.initials: E
authors.lastname: Ramírez
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood*; D002648:Child; D002677:Chile; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008457:Measles / Q000276:immunology*; D008458:Measles Vaccine / Q000276:immunology; D008459:Measles virus / Q000276:immunology*; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000276:immunology; D012412:Rubella virus / Q000276:immunology; D016036:Seroepidemiologic Studies
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine; D012411:Rubella Vaccine
vernacular_title: Estado inmunitario de 4 grupos de edad de población chilena contra sarampión y rubeola.